Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 7.91 million shares were traded. MPW stock price reached its highest trading level at $5.03 during the session, while it also had its lowest trading level at $4.95.
Ratios:
To gain a deeper understanding of MPW’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.55 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.32. For the most recent quarter (mrq), Quick Ratio is recorded 2.68 and its Current Ratio is at 2.68. In the meantime, Its Debt-to-Equity ratio is 2.06 whereas as Long-Term Debt/Eq ratio is at 2.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for the company, Exane BNP Paribas on March 12, 2025, Upgraded its rating to Outperform and sets its target price to $9 from $5 previously.
On September 13, 2024, Colliers Securities Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $6.50.
Exane BNP Paribas Downgraded its Outperform to Neutral on July 02, 2024, while the target price for the stock was maintained at $4.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 05 ’25 when Stewart Michael G sold 29,000 shares for $5.20 per share. The transaction valued at 150,800 led to the insider holds 216,100 shares of the business.
Stewart Michael G bought 29,000 shares of MPW for $150,800 on May 05 ’25. On Mar 05 ’25, another insider, Hanna James Kevin, who serves as the Senior VP, Controller & CAO of the company, bought 7,411 shares for $5.75 each. As a result, the insider paid 42,613 and bolstered with 372,338 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MPW now has a Market Capitalization of 2995470080 and an Enterprise Value of 12216123392. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.21 while its Price-to-Book (P/B) ratio in mrq is 0.64. Its current Enterprise Value per Revenue stands at 12.105 whereas that against EBITDA is 17.248.
Stock Price History:
The Beta on a monthly basis for MPW is 1.49, which has changed by 0.15545249 over the last 52 weeks, in comparison to a change of 0.1476624 over the same period for the S&P500. Over the past 52 weeks, MPW has reached a high of $6.34, while it has fallen to a 52-week low of $3.51. The 50-Day Moving Average of the stock is -1.38%, while the 200-Day Moving Average is calculated to be 1.50%.
Shares Statistics:
It appears that MPW traded 8.51M shares on average per day over the past three months and 9214620 shares per day over the past ten days. A total of 601.14M shares are outstanding, with a floating share count of 496.04M. Insiders hold about 17.55% of the company’s shares, while institutions hold 55.63% stake in the company. Shares short for MPW as of 1761868800 were 154482885 with a Short Ratio of 18.16, compared to 1759190400 on 158416266. Therefore, it implies a Short% of Shares Outstanding of 154482885 and a Short% of Float of 36.900002.
Dividends & Splits
With its trailing 12-month dividend rate of 0.32, MPW has a forward annual dividend rate of 0.32. Against a Trailing Annual Dividend Yield of 0.064257026. The stock’s 5-year Average Dividend Yield is 9.97.
Earnings Estimates
The market rating of Medical Properties Trust Inc (MPW) is currently shaped by the ongoing analysis conducted by 6.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.02, with high estimates of $0.02 and low estimates of $0.02.
Analysts are recommending an EPS of between $0.24 and -$0.35 for the fiscal current year, implying an average EPS of -$0.23. EPS for the following year is $0.12, with 1 analysts recommending between $0.12 and $0.12.
Revenue Estimates
In. The current quarter, 5 analysts expect revenue to total $248.78M. It ranges from a high estimate of $273.66M to a low estimate of $236.85M. As of. The current estimate, Medical Properties Trust Inc’s year-ago sales were $231.84MFor the next quarter, 5 analysts are estimating revenue of $262.53M. There is a high estimate of $272.3M for the next quarter, whereas the lowest estimate is $253.8M.
A total of 5 analysts have provided revenue estimates for MPW’s current fiscal year. The highest revenue estimate was $1.09B, while the lowest revenue estimate was $935.54M, resulting in an average revenue estimate of $979.85M. In the same quarter a year ago, actual revenue was $995.55MBased on 5 analysts’ estimates, the company’s revenue will be $1.04B in the next fiscal year. The high estimate is $1.1B and the low estimate is $981.14M.
